Under one roof: identification, evaluation, and treatment of chronic hepatitis C in addiction care
Martin, Stephen A ; Bosse, Jordon ; Wilson, Amanda ; Losikoff, Phyllis ; Chiodo, Lisa
Citations
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Publication Date
Keywords
Cirrhosis
Continuity of care
Hepatitis C epidemiology
Hepatitis C treatment
Opioid use disorder
Project ECHO
Treatment cascade
Clinical Epidemiology
Community Health and Preventive Medicine
Epidemiology
Health Services Administration
Health Services Research
Substance Abuse and Addiction
Virus Diseases
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
For over a decade, the vast majority of new hepatitis C virus (HCV) infections have been among young people who inject drugs (PWID). Well-characterized gaps in chronic HCV diagnosis, evaluation, and treatment have resulted in fewer than 5% of PWID receiving HCV treatment. While interferon-based treatment may have intentionally been foregone during part of this time in anticipation of improved oral therapies, the overall pattern points to deficiencies and treatment exclusions in the health care system. Treatment for HCV with all-oral, highly effective direct-acting antiviral medication for 12 weeks or less is now the standard of care, putting renewed focus on effective delivery of care. We describe here both the need for and process of chronic HCV care under the roof of addiction medicine.
Source
Addict Sci Clin Pract. 2018 Apr 25;13(1):10. doi: 10.1186/s13722-018-0111-7. Link to article on publisher's site